Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Ovarian Neoplasms

Free Subscription 29.06.2020 1 Ann Oncol 1 Br J Cancer 4 Gynecol Oncol 1 J Clin Oncol 1 Lancet Oncol 1 Nat Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Oncol

1. MIRZA MR, Coleman RL, Gonzalez-Martin A, Moore KN, et al
   The forefront of ovarian cancer therapy: update on PARP inhibitors.
   Ann Oncol. 2020 Jun 19. pii: S0923-7534(20)39891.
   PubMed         Abstract available
   
   

   
   Br J Cancer

2. MARTINS FC, Couturier DL, Paterson A, Karnezis AN, et al
   Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.
   Br J Cancer. 2020 Jun 18. pii: 10.1038/s41416-020-0900.
   PubMed         Abstract available
   
   

   
   Gynecol Oncol

3. LAGO V, Fotopoulou C, Chiantera V, Minig L, et al
   Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction.
   Gynecol Oncol. 2020 Jun 19. pii: S0090-8258(20)31132.
   PubMed         Abstract available
   
   
4. DILLEY J, Burnell M, Gentry-Maharaj A, Ryan A, et al
   Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
   Gynecol Oncol. 2020 Jun 16. pii: S0090-8258(20)31029.
   PubMed         Abstract available
   
   
5. NICA A, Covens A, Parra-Herran C, May T, et al
   Does timing of intraperitoneal chemotherapy initiation following primary cytoreductive surgery with bowel resection impact outcomes in patients with advanced ovarian cancer?
   Gynecol Oncol. 2020 Jun 16. pii: S0090-8258(20)32293.
   PubMed         Abstract available
   
   
6. MARCHETTI C, Minucci A, D'Indinosante M, Ergasti R, et al
   Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach.
   Gynecol Oncol. 2020 Jun 15. pii: S0090-8258(20)32294.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

7. TEWARI KS, Monk BJ, Burger RA
   Reply to Farolfi et al and Haines et al.
   J Clin Oncol. 2020;38:173-174.
   PubMed        
   
   

   
   Lancet Oncol

8. KONSTANTINOPOULOS PA, Cheng SC, Wahner Hendrickson AE, Penson RT, et al
   Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.
   Lancet Oncol. 2020 Jun 15. pii: S1470-2045(20)30180.
   PubMed         Abstract available
   
   

   
   Nat Med

9. IZAR B, Tirosh I, Stover EH, Wakiro I, et al
   A single-cell landscape of high-grade serous ovarian cancer.
   Nat Med. 2020 Jun 22. pii: 10.1038/s41591-020-0926.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: